Citadel Advisors
AUVI

Citadel Advisors’s Applied UV, Inc. Common Stock AUVI Stock Holding History

Citadel Advisors’s Portfolio AUVI Stock Details AUVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,804
Closed -$38.7K – 15595
2023
Q3 		$38.7K Buy
+4,804
New +$80.4K ﹤0.01% 12037
2021
Q3 		– Sell
-118
Closed -$144K – 14927
2021
Q2 		$144K Buy
+118
New +$137K ﹤0.01% 12541

Other funds holding AUVI

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors's AUVI Position: Q4 2023 in Review

Citadel Advisors sold out of Applied UV, Inc. Common Stock (AUVI) in Q4 2023, closing a stake of 4,804 shares — an estimated $38.7K sold.

Citadel Advisors first reported a position in AUVI in Q2 2021 and held it in 2 quarters. The position peaked at $144K in Q2 2021. 5 funds tracked by Wall St. Rank hold AUVI as of Q4 2023.

  • Citadel Advisors reported no remaining Applied UV, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 4,804 Applied UV, Inc. Common Stock shares in Q4 2023, an estimated $38.7K.
  • Citadel Advisors first reported a position in Applied UV, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Citadel Advisors's Applied UV, Inc. Common Stock position peaked at $144K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Applied UV, Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.